References
- Ambuja SB, Elaina K, Thomas JF, John CL, Donna LM, Thomas H, Geoffrey WP. (2013). Correlating in vitro data to in vivo findings for risk assessment. Altex31: 1/14. Symposium report.10.14573/altex.1310011
- Arwa BR, Vladimir BB. (2016). In silico toxicology: computational methods for the prediction of chemical toxicity. Wiley Interdiscip Rev Comput Mol Sci. 6: 147–172.10.1002/wcms.1240
- Blais A, Morvan-Baleynaud J, Friedlander G, Le Grimellec C. (1993). Primary culture of rabbit proximal tubules as a cellular model to study nephrotoxicity of xenobiotics. Kidney Int44: 13–18.10.1038/ki.1993.206
- Botham PA. (2004). Acute systemic toxicity—prospects for tiered testing strategies. Toxicol in Vitro18: 227–230.10.1016/S0887-2333(03)00143-7
- Broadhead CL, Combes RD. (2001). The current status for food additives toxicity testing and the potential for application of the Three Rs. ATLA29: 471–485.10.1177/026119290102900403
- Brown MJ, White WJ. (2009). Reflections on improved health status of rodents bred for research: contributions to the reduction and refinement of animal use. Altern Lab Anim37: 187–189.10.1177/026119290903700207
- Chapman KL, Holzgrefe H, Black LE, Brown M, Chellman G, Copeman C, Couch J, Creton S, Gehen S, Hoberman A, Kinter LB, Madden S, Mattis C, Stemple HA Wilson S. (2013). Pharmaceutical toxicology: Designing studies to reduce animal use, while maximizing human translation. Regul. Toxicol. Pharmacol66: 88–103.10.1016/j.yrtph.2013.03.001
- Clemedson C, Barile FA, Chesne C, Cottin M, Curren R, Eckwall B, Ferro M, Gomez-Lechon MJ, Imai K, Janus J, Kemp RB, Kerszman G, Kjellstrand P, Lavrijsen K, Logemann P, McFarlane-Abdulla E, Roguet R, Segner H, Thuvander A, Walum E, Ekwall B. (2000). MEIC evaluation of acute systemic toxicity. Part VII. Prediction of human toxicity by results from testing of the first 30 reference chemicals with 27 further in vitro assays. ATLA28: 159–200.
- Coecke S, Ahr H, Blaauboer BJ, Bremer S, Casati S, Castell J, Combes R, Corvi R, Crespi CL, Cunningham ML. (2006). Metabolism: A bottleneck in in vitro toxicological test development. ATLA. 34: 49–84.10.1177/026119290603400113
- Cronin MTD. (2002). The current status and future applicability of quantitative structure–activity relationships (QSARs) in predicting toxicity. ATLA30: 81–84.10.1177/026119290203002S12
- Daneshian M. (2012). A roadmap for the development of alternative (non-animal) methods for toxicokinetics testing. ALTEX29: 16–26.
- Dayna KM, Alan MG, Albrecht P, Michael FW, Joseph C, James M, Kelly PC, Richard H, Ronald B, Harald FK, Anthony B, Thomas H. (2017). From In Vivo to In Vitro: The Medical Device Testing Paradigm Shift. t4 workshop report*. ALTEX Online first published, version 2 doi: 10.14573/altex.1608081.10.14573/altex.160808128539002
- Deora PS, Mishra CK, Mavani P, Asha R, Shrivastava B, Rajesh KN. (2010). Effective alternative methods of LD50 help to save number of experimental animals. J Chem Pharm Res2(6): 450–453.
- Ekwall B. (1999). Overview of the Final MEIC Results: II. The In Vitro–In Vivo Evaluation, Including the Selection of a Practical Battery of Cell Tests for Prediction of Acute Lethal Blood Concentrations in Humans. Toxicol in Vitro13: 665–673.10.1016/S0887-2333(99)00061-2
- Enegide C, David A, Fidelis SA. (2013). A New Method for Determining Acute Toxicity in Animal Models. Toxicol Int20(3): 224–226.10.4103/0971-6580.121674
- Erkekoglu P, Giray BK, Basaran N. (2011). 3R Principle and Alternative Toxicity Testing Methods. FABAD J Pharm Sci36: 101–117.
- Escher SE, Tluczkiewicz I, Batke M. (2010). Evaluation of inhalation TTC values with the database RepDose. Regul Toxicol Pharmacol58: 259–274.10.1016/j.yrtph.2010.06.009
- EURL-ECVAM (2017). European Union Reference Laboratory for Alternative to Animal Testing https://eurl-ecvam.jrc.ec.europa.eu/glossary/glossary/invitro-methods. Accessed on 17th November, 2017.
- Fisher G. (2013). Import Ban on Animal-Tested Products Goes Into Effect. The Times of Israel, 1 January 2013. https://www.timesofisrael.com/import-ban-on-animal-tested-products-goes-into-effect/. Accessed on November, 2th, 2017.
- Gallagher ME. (2003). Toxicity testing requirements, methods and proposed alternatives. Environs26(2): 257–273.
- Gertrude-Emilia C. (2017). Advances in science: next generation of lab tools, models and testing platforms used in predictive toxicology. Molecular Life1(1): 22–28.10.26600/MolLife.1.1.3.2017
- Hamm J, Kristie S, Amy JC, Judy S, Shannon B, Barun B, Bas B, Warren C, David D, Anna F, Natàlia GR, Sean G, Rabea G, Jon H, Anna L, Joanna M, Elissa R, Louis S, David A. (2017). Alternative approaches for identifying acute systemic toxicity: Moving from research to regulatory testing. Toxicol in Vitro41: 245–259.10.1016/j.tiv.2017.01.004
- Hartung T, McBride M. (2011). Food for thought. on mapping the human toxome. ALTEX28: 83–93.10.14573/altex.2011.2.083
- Hartung T, Daston G. (2009). FORUM Are In Vitro Tests Suitable for Regulatory Use? Toxicol Sci111(2): 233–237.10.1093/toxsci/kfp14919617452
- ICCVAM (2006). Test Method Evaluation Report – In Vitro Ocular Toxicity Test Methods for Identifying Ocular Severe Irritants and Corrosives. Inter-agency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and the National Toxicology Program (NTP) Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM). NIH Publication No.: 07-4517. Available: [http://iccvam.niehs.nih.gov/methods/ocutox/ivocutox/ocu_tmer.htm].
- ICCVAM (1999). Corrositex®. An In Vitro Test Method for Assessing Dermal Corrosivity Potential of Chemicals. The Results of an Independent Peer Review Evaluation Coordinated by ICCVAM, NTP and NICEATM. NIEHS, NIH Publication (No. 99-4495.)
- Jannuzzi AT, Ozcagli1 E, Kovatsi L, Goumenou M and Tsatsakis AM. (2016). Using Stem Cells in Toxicological Assessments. J Med Toxicol Clin Forens Med2(1): 1–2.10.21767/2471-9641.100015
- Jen-Yin G, Richard JW, Libby D, Nicola JP, Ruth AR (2015). Development and use of in vitro alternatives to animal testing by the pharmaceutical industry 1980–2013. Toxicol Res4: 1297–1307.10.1039/C5TX00123D
- Kleandrova VV, Luan F, Speck-Planche A, Cordeiro MN (2015). In silico assessment of 26 the acute toxicity of chemicals: recent advances and new model for multitasking 27 prediction of toxic effect. Mini Rev Med Chem15: 677–86.10.2174/1389557515666150219143604
- Loomis TA, Hayes AW. (1996). Loomis’s essentials of toxicology. 4th ed., California, Academic press: 208–245.10.1016/B978-012455625-6/50014-3
- Lorke D. (1983). A new approach to practical acute toxicity testing. Arch Toxicol 54: 275–87.10.1007/BF01234480
- Maheshwari DG, Shaikh NK. (2016). An overview on toxicity testing method. Int J Pharm Technol8(2): 3834–3849.
- Marx U, Andersson TB, Bahinski A. (2016). Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing using animals. ALTEX33: 272–321.10.14573/altex.1603161
- OECD (2001). Acute Oral Toxicity – Acute Toxic Class Method. Test No. 423. Adopted 17th December, 2001.
- Parasuraman S. (2011). Toxicological screening. J Pharmacol Pharmacother2(2): 74–79.10.4103/0976-500X.81895
- Peers IS, Ceuppens PR, Harbron C. (2012). In search of preclinical robustness. Nat Rev Drug Discov11(10): 733–734.10.1038/nrd3849
- PISC (2017). Peta International Science Consortium Ltd. Alternatives to animal testing. www.piscltd.org.uk.
- Randhawa MA. (2009). Calculation of LD50 value from the method of Miller and Tainter, 1944. J Ayub Med Coll Abbottabad21(3): 1–3.
- Robinson V. (2005). Finding alternatives: an overview of the 3Rs and the use of animals in research. School Sci Rev87: 1–4.
- Russell WMS, Burch RL. (1959). The Principles of Humane Experimental Technique. Methuen, London. Stephens ML, Goldberg AM, Rowan AN, 2001. The First Forty Years of Alternatives Approach: Refining, Reducing, and Replacing the Use of Laboratory Animals. In: Salem DJ, Rowan AN (Eds.), The State of Animals. Humane Society Press, Washington, DC. 121–135.
- Rust A, Doran C, Hart R, Binz T, Stickings P, Sesardic D, Peden AA Davletov B. (2017). A Cell Line for Detection of Botulinum Neurotoxin Type B. Front Pharmacol8: 796: 1–8.10.3389/fphar.2017.00796
- Saganuwan AS. (2011). A modified arithmetical method of Reed and Muench for determination of a relatively ideal median lethal dose (LD50). Afr J Pharm5(12): 1543–1546.10.5897/AJPP11.393
- Saganuwan SA. (2016). Toxicity study of drugs and chemicals in animals: An overview. BJVM. 2016 online first. ISSN 1311-1477.
- Shanks N, Greek R, Greek J. (2009). Are animal models predictive for humans? Philos. Ethics Humanit Med4(2): 1–20. Available from: http://www.pehmed.com/content/4/1/2.10.1186/1747-5341-4-2
- Sonali K, Doke S, Dhawale C. (2015). Alternatives to animal testing: A review. Saudi Pharm J23: 223–229.10.1016/j.jsps.2013.11.002
- Valerio-Jr, LG. (2009). In silico toxicology for the pharmaceutical sciences. Toxicol Appl Pharmacol241: 356–370.10.1016/j.taap.2009.08.022